0.6901
price up icon1.94%   0.0131
after-market Dopo l'orario di chiusura: .72 0.0299 +4.33%
loading

Salarius Pharmaceuticals Inc Azioni (SLRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
82.51%
1.7716
0.9707 2.5322 3.9714 5.4207
Operating Income/Loss
82.51%
-1.7716
-0.9707 -2.5322 -3.9714 -5.4207
Income/Loss From Continuing Operations Before Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Income/Loss From Continuing Operations After Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Net Income/Loss
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Diluted Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Basic Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Diluted Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.23%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):